YKL-39 induces monocytes migration and angiogenesis and inversely correlates with metastasis in patients with breast cancer

Date

11 Sep 2017

Session

Poster display session

Presenters

Irina Mitrofanova

Citation

Annals of Oncology (2017) 28 (suppl_5): v573-v594. 10.1093/annonc/mdx390

Authors

I. Mitrofanova1, L. Tengfei2, M. Zavyalova3, N. Litviakov4, M. Buldakov5, N. Cherdyntseva5, J. Kzhyshkowska6

Author affiliations

  • 1 Laboratory Of Translational Cellular And Molecular Biomedicine, Tomsk State University, 634050 - Tomsk/RU
  • 2 Medical Faculty Mannheim,institute Of Transfusion Medicine And Immunology, University of Heidelberg, Mannheim/DE
  • 3 Department Of Pathological Anatomy, Siberian State Medical University, Tomsk/RU
  • 4 Laboratory Of Virusology, Tomsk Cancer Research Institute RAMS, Tomsk/RU
  • 5 Laboratory Of Molecular Oncology And Immunology, Tomsk Cancer Research Institute RAMS, Tomsk/RU
  • 6 Institute Of Transfusion Medicine And Immunology, German Red Cross Blood Service Baden-Württemberg – Hessen, Mannheim/DE
More

Resources

Background

Human chitinase-like proteins are considered as biomarkers of cancer and chronic inflammation.YKL-39 is a unique member of chitinase-like protein family due to its presence only in humans but not in rodents both on gene and protein levels. However, its biological activity and association with tumor progression remains unknown.

Methods

YKL-39 expression and secretion in human monocytes-derived macrophages was measured by RT-PCR and ELISA. Monocyte migration was analyzed in a trans-well system. In vitro tube formation assay was performed using HUVEC cells.112 female patients with nonspecific invasive breast cancer of stage IIA-IIIC (T1-4N0-3M0) were included in the study. Confocal microscopy analysis was used to identify cell type expressing YKL-39 in tumor samples.YKL-39 expression level was measured by RT-PCR in tumor biopsy specimens.

Results

Human monocytes-derived macrophages differentiated in the presence of IL4 and TGFbeta, but not IL4 alone, were found to express high levels of YKL-39 mRNA and protein. Purified YKL-39 significantly enhanced the migration of human CD14+monocytes by 1.9 fold (p 

Conclusions

TGFbeta is a key cytokine inducing production of YKL-39 in macrophages. YKL-39 stimulates critical for tumor progression processes: chemotaxis of monocytes and angiogenesis. However high levels of YKL-39 expression in tumor samples are predictive for metastatic-free survival in patients with breast cancer, suggesting that YKL-39 can program monocytes and newly growing vessels to inhibit metastatic spread.

This study was supported by grant RNF №14-15-00350.

Clinical trial identification

Legal entity responsible for the study

Tomsk State University, Tomsk, Russian Federation

Funding

Tomsk State University, Tomsk, Russian Federation. This study was supported by grant RNF №14-15-00350.

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings